Cargando…
Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection
Both hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are a major global healthcare problem with more than 240 million and 70 million infected, respectively. Both viruses persist within the liver and result in progressive liver disease, resulting in liver fibrosis, cirrhosis and hepato...
Autores principales: | Ortega-Prieto, Ana Maria, Dorner, Marcus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620555/ https://www.ncbi.nlm.nih.gov/pubmed/28862649 http://dx.doi.org/10.3390/vaccines5030024 |
Ejemplares similares
-
Phosphodiesterase-induced cAMP degradation restricts hepatitis B virus infection
por: Evripioti, Antonia Alexandra, et al.
Publicado: (2019) -
In Vivo Model Systems for Hepatitis
B Virus Research
por: Ortega-Prieto, Ana Maria, et al.
Publicado: (2018) -
Characterization of antigenic variants of hepatitis C virus in immune evasion
por: Wang, Jane H, et al.
Publicado: (2011) -
The Hepatitis C Virus Glycan Shield and Evasion of the Humoral Immune Response
por: Helle, François, et al.
Publicado: (2011) -
Hepatitis C Virus Evasion from RIG-I-Dependent Hepatic Innate Immunity
por: Liu, Helene Minyi, et al.
Publicado: (2010)